- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Dr Soliman Abdel Kader Fakeeh (4017)
Dr Soliman Abdel Kader Fakeeh stock price live, this page displays TADAWUL 4017 stock exchange data. View the 4017 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Dr Soliman Abdel Kader Fakeeh real time stock price chart below.
What Is the Dr Soliman Abdel Kader Fakeeh Stock Price Today?
The Dr Soliman Abdel Kader Fakeeh stock price today is 40.10.
What Is the Stock Symbol for Dr Soliman Abdel Kader Fakeeh?
The stock symbol for Dr Soliman Abdel Kader Fakeeh is ""4017.""
What Stock Exchange Does Dr Soliman Abdel Kader Fakeeh Trade On?
Dr Soliman Abdel Kader Fakeeh is listed and trades on the Saudi Arabia stock exchange.
Is Dr Soliman Abdel Kader Fakeeh a Good Stock to Buy?
Determining whether Dr Soliman Abdel Kader Fakeeh—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4017 quote. (ISIN: SA562GSHUOH7)
What Is the Dr Soliman Abdel Kader Fakeeh Stock Price Today?
The Dr Soliman Abdel Kader Fakeeh stock price today is 40.10.
What Is the Stock Symbol for Dr Soliman Abdel Kader Fakeeh?
The stock symbol for Dr Soliman Abdel Kader Fakeeh is ""4017.""
What Stock Exchange Does Dr Soliman Abdel Kader Fakeeh Trade On?
Dr Soliman Abdel Kader Fakeeh is listed and trades on the Saudi Arabia stock exchange.
Is Dr Soliman Abdel Kader Fakeeh a Good Stock to Buy?
Determining whether Dr Soliman Abdel Kader Fakeeh—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4017 quote. (ISIN: SA562GSHUOH7)
Saudi Arabia
Currency in SAR
40.10
+0.10(+0.25%)
Delayed Data·
Fair Value
An estimate of a Dr Soliman Abdel Kader Fakeeh's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
40.00
40.26
52 wk Range
37.10
72.90
4017 Scorecard
Full Analysis
Suffers from weak gross profit margins
4017 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Dr Soliman Abdel Kader Fakeeh's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
40.0040.26
52 wk Range
37.1072.90
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.75%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.75%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4017 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Dr Soliman Abdel Kader Fakeeh's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Neutral
Price Target
48.45
Upside
+20.82%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Healthcare Providers & Services industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Dr Soliman Abdel Kader Fakeeh Company Profile
Dr. Soliman Abdel Kader Fakeeh Hospital Company, together with its subsidiaries, establishes, operates, and manages hospitals, clinics, medical, educational, and training centers in the Kingdom of Saudi Arabia. It operates through Medical Services; Education; and Trading, Retail & Others segments. The company offers various services, such as assisted reproductive therapy, audiology, bariatric surgery, pediatric, breast feeding, cardiac surgery, cardiology, chest and respiratory diseases, chiropractic medicine, dental and maxillofacial, dermatology, otorhinolaryngology, endocrinology, ophthalmology, family medicine, gastroenterology, general surgery, geriatric medicine, hematology, hyperbaric oxygen service, infectious diseases, internal medicine, interventional radiology, psychiatry, lasik surgery, nephrology, neuro surgery, neurology, nutrition, obstetrics and gynecology, oncology, orthopedics, pediatric orthopedic surgery, pediatric surgery, physical medicine and rehabilitation, plastic surgery, rheumatology, sleep disorders clinic, speech therapy, thoracic surgery, urology, and vascular surgery, as well as pain treatment and palliative care services. It also operates AIRS, anesthesia, burn, diagnostics service, emergency medicine, endoscopy, intensive care, NICU, renal dialysis, rhinoplasty, and institute of robotic surgery facilities; establishes and manages pharmacies; and provides analysis and radiology laboratory, healthcare, medical education, and home health care services. In addition, the company engages in the trading of pharmaceutical products, spectacles, and cosmetics; construction and contracting; wholesale and retail of medical equipment; and maintenance of IT equipment and software related services. The company was incorporated in 1978 and is based in Jeddah, the Kingdom of Saudi Arabia.
Compare 4017 to Peers and Sector
Metrics to compare | 4017 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4017PeersSector | |
|---|---|---|---|---|
P/E Ratio | 32.1x | 22.1x | −0.5x | |
PEG Ratio | −3.63 | 0.59 | 0.00 | |
Price/Book | 3.0x | 3.0x | 2.6x | |
Price / LTM Sales | 3.3x | 4.2x | 3.3x | |
Upside (Analyst Target) | 12.0% | 21.1% | 43.3% | |
Fair Value Upside | Unlock | −0.5% | 6.9% | Unlock |
Analyst Ratings
1 Buy
3 Hold
2 Sell
Ratings:
6 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 48.45
(+20.82% Upside)
Earnings
Latest Release
May 28, 2025
EPS / Forecast
0.31 / --
Revenue / Forecast
701.00M / --
People Also Watch
FAQ
What Stock Exchange Does Dr Soliman Abdel Kader Fakeeh Trade On?
Dr Soliman Abdel Kader Fakeeh is listed and trades on the Saudi Arabia Stock Exchange stock exchange.
What Is the Stock Symbol for Dr Soliman Abdel Kader Fakeeh?
The stock symbol for Dr Soliman Abdel Kader Fakeeh is "4017."
What Is the Dr Soliman Abdel Kader Fakeeh Market Cap?
As of today, Dr Soliman Abdel Kader Fakeeh market cap is 9.20B.
What Is Dr Soliman Abdel Kader Fakeeh's Earnings Per Share (TTM)?
The Dr Soliman Abdel Kader Fakeeh EPS (TTM) is 1.28.
When Is the Next Dr Soliman Abdel Kader Fakeeh Earnings Date?
Dr Soliman Abdel Kader Fakeeh will release its next earnings report on 02 Sept 2025.
From a Technical Analysis Perspective, Is 4017 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Dr Soliman Abdel Kader Fakeeh Stock Split?
Dr Soliman Abdel Kader Fakeeh has split 0 times.
How Many Employees Does Dr Soliman Abdel Kader Fakeeh Have?
Dr Soliman Abdel Kader Fakeeh has 2672 employees.
What is the current trading status of Dr Soliman Abdel Kader Fakeeh (4017)?
As of 11 Aug 2025, Dr Soliman Abdel Kader Fakeeh (4017) is trading at a price of 40.10, with a previous close of 40.00. The stock has fluctuated within a day range of 40.00 to 40.26, while its 52-week range spans from 37.10 to 72.90.
What Is Dr Soliman Abdel Kader Fakeeh (4017) Price Target According to Analysts?
The average 12-month price target for Dr Soliman Abdel Kader Fakeeh is SAR48.45, with a high estimate of SAR62 and a low estimate of SAR37. 1 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Neutral. The stock has an +20.82% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.